Saturday , December 16 2017
Home / KEEP BUT DO NOT DISPLAY (page 5)

KEEP BUT DO NOT DISPLAY

Putting ‘Added Sugars’ on Food Labels Confuses Shoppers

In a recent study, consumers who viewed nutrition panels with grams of "added sugars" as part of total grams of sugar miscalculated the amount of sugar. But when consumers looked at a nutrition panel that didn’t break out "added sugars," most of them correctly identified the amount of sugar. The …

Read More »

Substandard Care for Diabetes in Diabetes Clinics

Diabetes subspecialty and primary care clinics showed low control rates of A1C, LDL cholesterol and microalbuminuria, compared with family practice and internal medicine clinics, according to a study. While the rates of HbA1c, LDL-cholesterol and microalbuminuria testing appear to be high in both diabetes subspecialty and primary care clinics, the …

Read More »

Eating Just a Handful of Nuts Daily Lowers Risk of Death from Diseases

Previous research has hailed peanuts and nuts for their health benefits. Now, a new study supports such research, finding that consuming these foods may protect against death from numerous diseases, including cancer, heart disease and diabetes. The study results revealed that participants who consumed around 15 grams of nuts or …

Read More »

More Evidence Showing Health Benefits of Chocolate

A study that followed almost 21,000 adults for an average of 12 years found those who ate the most chocolate had lower heart attack, stroke and diabetes rates, along with lower BMI, blood pressure and inflammation, when compared with people who consumed the least chocolate. Researchers, who reported the findings …

Read More »

FDA Panel Favors Approval of Alirocumab for Hypercholesterolemia

The FDA’s Endocrinologic and Metabolic Advisory Committee has recommended approval of the first PCSK9 inhibitor alirocumab (Praluent, Regeneron and Sanofi) injection for treatment of hypercholesterolemia. In a 13-3 vote, the panel decided that the LDL-lowering benefit of alirocumab outweighed the risks in one or more patient populations. The committee based …

Read More »

Predicting Future Cardiovascular Events By Missing Teeth

Advanced tooth loss can often indicate that a person has a history of inflammatory oral diseases. In an extensive cohort study, carried out by the University of Helsinki (Finland) in collaboration with The National Institute for Health and Welfare (THL), an association was found between tooth loss and future cardiovascular …

Read More »

FDA Panel Favors Approval of Alirocumab and Evolocumab for Hypercholesterolemia

FDA Panel Favors Approval of Alirocumab and Evolocumab for Hypercholesterolemia.  Two PCSK9 inhibitors have been recommended for approval. The agency will likely follow the advisory committee’s advice when it decides whether to approve the drugs, alirocumab (Praluent) from Sanofi SA and Regeneron Pharmaceuticals Inc., and evolocumab (Repatha) from Amgen Inc., for …

Read More »

Exposure to Staph Toxins May Cause Type 2 Diabetes

Researchers have found that weight gain puts people at an increased risk of being colonized by staphylococcus aureus bacteria on their skin. A toxin released by the bacteria has also been connected with symptoms of type 2 diabetes. The researchers examined four diabetes patients and discovered that their estimated exposure …

Read More »